Daniel Muehl

OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO.

SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO.

SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO.

OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO.

SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO.

OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO.

OPX Biotechnologies, Inc. engages in the development and production of bio-based chemicals and fuels. The company was founded by Ryan T. Gill, Peter Long, and Michael Lynch in 2007 and is headquartered in Boulder, CO.

SomaLogic Operating Co., Inc. engages in the development of technologies used in the areas of diagnostics, clinical research, and pharmaceutical development. It offers protein biomarker systems for applications in drug discovery, therapeutic treatments, and wellness monitoring. The firm's products and services include SOMAscan service, SOMAscan at the institution, individual SOMAscan reagents, SOMAmer discovery service, SomaLogic CLIA laboratory, and technical support. The company was founded by Larry Gold and David Brunel in 2000 and is headquartered in Boulder, CO.